Cyclacel Pharmaceuticals Inc (CYCC)

08:45 AM

Fitters plans to sell full stake in unit to US biotech firm - The Malaysian Reserve

08:45 AM

Apr 03, 2025

Cyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development - TipRanks

Apr 03, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Apr 02, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift - TipRanks

Apr 02, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results And Provides Business Update - MarketScreener

Apr 02, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times

Apr 02, 2025

Apr 02, 2025

Cyclacel Slashes Net Loss in Half, Streamlines to Focus on Promising Cancer Drug - Stock Titan

Apr 02, 2025

Mar 31, 2025

Cyclacel Pharmaceuticals Delays 10-K Filing - TipRanks

Mar 31, 2025

Mar 31, 2025

CYCC stock touches 52-week low at $0.29 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

CYCC stock touches 52-week low at $0.29 amid sharp annual decline - Investing.com

Mar 31, 2025

Mar 31, 2025

StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025

Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025

Mar 26, 2025

Cyclacel Pharmaceuticals to offer convertible preferred stock in private placement - MSN

Mar 26, 2025

Mar 24, 2025

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering Of Convertible Preferred Stock - Marketscreener.com

Mar 24, 2025

Mar 24, 2025

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock - The Manila Times

Mar 24, 2025

Mar 24, 2025

Cyclacel's Latest $1M Financing Deal Reveals Extended Survival Strategy Through Q3 2025 - Stock Titan

Mar 24, 2025

Mar 23, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World

Mar 23, 2025

Mar 17, 2025

Cyclacel Pharmaceuticals’ Change of Control Transaction and Appointment of New Executive Leadership - Global Legal Chronicle

Mar 17, 2025

Mar 17, 2025

(CYCCP) Trading Advice - news.stocktradersdaily.com

Mar 17, 2025

Mar 16, 2025

Cyclacel Pharmaceuticals (CYCC) Projected to Post Earnings on Tuesday - The AM Reporter

Mar 16, 2025

Mar 15, 2025

CYCLACEL PHARMACEUTICALS Earnings Preview: Recent $CYCC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025

Mar 15, 2025

StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 15, 2025

Mar 14, 2025

Cyclacel Pharmaceuticals acquires cancer drug assets By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Cyclacel Pharmaceuticals acquires cancer drug assets - Investing.com

Mar 14, 2025

Mar 12, 2025

Cyclacel stock plunges to 52-week low at $0.3 amid market challenges - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

Cyclacel stock plunges to 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 09, 2025

Cyclacel stock plunges to 52-week low of $0.31 amid market challenges - MSN

Mar 09, 2025

Mar 07, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World

Mar 07, 2025

Mar 07, 2025

Cyclacel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Feb 28, 2025

Cyclacel Pharmaceuticals interim CEO David Lazar sells $5.5 million in stock - Investing.com India

Feb 28, 2025

Feb 27, 2025

Cyclacel Pharmaceuticals Announces New Leadership and Restructuring - TipRanks

Feb 27, 2025

Feb 27, 2025

Cyclacel Pharmaceuticals Says Datuk Dr.Doris Wong Sing Ee Elected As CEO & Executive Director - Marketscreener.com

Feb 27, 2025

Feb 27, 2025

Cyclacel Pharmaceuticals Expands Executive Leadership Team - citybiz

Feb 27, 2025

Feb 27, 2025

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership - The Manila Times

Feb 27, 2025

Feb 27, 2025

Investor Network: Cyclacel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Who Now Controls Cyclacel? New Investor Takes 70% Ownership in $6.3M Leadership Overhaul - StockTitan

Feb 27, 2025

Feb 26, 2025

Buffett’s on the Sidelines – Should You Follow? - The Globe and Mail

Feb 26, 2025

Feb 24, 2025

Spiro Rombotis, CEO of Cyclacel Pharmaceuticals, on Innovative Targeted Therapies for Advanced - DocWire News

Feb 24, 2025

Feb 24, 2025

Cyclacel Pharmaceuticals amends agreement with CEO By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

Cyclacel Pharmaceuticals amends agreement with CEO - Investing.com

Feb 24, 2025

Feb 24, 2025

(CYCCP) Trading Report - news.stocktradersdaily.com

Feb 24, 2025

Feb 23, 2025

Head-To-Head Review: Cyclacel Pharmaceuticals (NASDAQ:CYCC) vs. Silence Therapeutics (NASDAQ:SLN) - Defense World

Feb 23, 2025

Feb 17, 2025

Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $25 million in funding from Helena Special Opportunities LLC - Marketscreener.com

Feb 17, 2025

Feb 16, 2025

Cyclacel Pharmaceuticals streamlines operations, plans asset purchase - MSN

Feb 16, 2025